ReviewCancers2025
Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma.
Katia Mancuso et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papertrialcites it
ReviewCancers2025
Katia Mancuso et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.